PRESS RELEASE published on 12/01/2025 at 08:00, 3 months 22 days ago Oxurion verzekert een bindende financieringsfaciliteit van EUR 30 miljoen voor investeringen in digitale activa en crypto activa Oxurion NV (Euronext Brussel: OXUR) unterzeichnet €30 Millionen Finanzierungsvereinbarung mit Atlas Capital Markets für Investitionen in Bitcoin und Ethereum Bitcoin Ethereum Oxurion NV Converteerbare Obligaties Finanzierungsvereinbarung
PRESS RELEASE published on 12/01/2025 at 08:00, 3 months 22 days ago Oxurion secures a binding EUR 30 million financing facility dedicated to investments in digital and crypto assets Oxurion NV secures €30 million financing via convertible bonds from Atlas Capital Markets to invest in digital assets like Bitcoin and Ethereum. The strategy aligns with the company's long-term investment policy Convertible Bonds Bitcoin Digital Assets Finance Oxurion NV
BRIEF published on 11/25/2025 at 18:05, 3 months 28 days ago Oxurion receives a transparency notification from Atlas Special Opportunities II LLC Actions Transparency Health Oxurion Atlas Special Opportunities II LLC
BRIEF published on 11/25/2025 at 18:05, 3 months 28 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actions Transparence Santé Oxurion Atlas Special Opportunities II LLC
PRESS RELEASE published on 11/25/2025 at 18:00, 3 months 28 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a change in share ownership. The company specializes in acquiring stakes in European pharmaceutical subcontractors Transparency Notification Share Ownership Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors
PRESS RELEASE published on 11/25/2025 at 18:00, 3 months 28 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV receives transparency notification from Atlas Special Opportunities II LLC regarding shareholding below 10%. Oxurion specializes in acquiring interests in European pharmaceutical subcontractors Transparency Notification Oxurion NV European Pharmaceutical Subcontractors
BRIEF published on 11/20/2025 at 18:05, 4 months 3 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Belgique Actifs Numériques Atlas Special Opportunities Notification De Transparence Oxurion
BRIEF published on 11/20/2025 at 18:05, 4 months 3 days ago Oxurion receives a transparency notification from Atlas Special Opportunities II LLC Digital Assets Transparency Notification Belgium Atlas Special Opportunities Oxurion
PRESS RELEASE published on 11/20/2025 at 18:00, 4 months 3 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC indicating a decrease in shareholding percentage due to sale of voting securities Transparency Notification Oxurion NV Voting Securities Atlas Special Opportunities II, LLC Shareholding Percentage
PRESS RELEASE published on 11/20/2025 at 18:00, 4 months 3 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV heeft aangekondigd dat het onder de drempel van 15% kwam na verkoop van aandelen. Het bedrijf specialiseert zich in Europese farmaceutische onderaannemers Transparantiekennisgeving Euronext Brussel Oxurion NV België Europese Farmaceutische Onderaannemers
Published on 03/23/2026 at 21:18, 48 minutes ago Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 8 hours 1 minute ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 8 hours 6 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 9 hours 1 minute ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 9 hours 34 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 21:05, 1 hour 1 minute ago Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 1 hour 1 minute ago Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 1 hour 5 minutes ago Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 20:55, 1 hour 10 minutes ago Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable
Published on 03/23/2026 at 19:08, 2 hours 57 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 2 hours 57 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 3 hours 28 minutes ago ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 4 hours 20 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 4 hours 20 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde